Related Experiment Video
Updated: Feb 23, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
Maturational Trajectory of Processing Speed Performance in Pediatric Multiple Sclerosis
Nadine Akbar1, Alessio Signori2, Maria Pia Amato3
1a School of Rehabilitation Therapy , Queen's University , Kingston , Ontario , Canada.
Insights
Processing speed, measured by the Symbol Digit Modalities Test (SDMT), matures in pediatric multiple sclerosis (MS) with age. Older age at onset and higher IQ may protect cognitive development in pediatric MS patients.
Area of Science:
- Neuroscience
- Pediatric Neurology
- Cognitive Science
Background:
- Processing speed is a key cognitive function often impaired in pediatric multiple sclerosis (MS).
- The Symbol Digit Modalities Test (SDMT) is a standard tool for assessing processing speed in this population.
Purpose of the Study:
- To investigate the developmental trajectories of processing speed in children and adolescents with MS.
- To identify baseline factors influencing these cognitive maturation patterns.
Main Methods:
- Analysis of SDMT performance data from 82 individuals with pediatric MS.
- Examination of age at disease onset and IQ as potential predictive factors for cognitive trajectories.
Main Results:
- SDMT performance demonstrated an initial increase with age, followed by a decline in pediatric MS patients.
- Older age at disease onset and higher IQ were associated with more significant cognitive gains over time.
Conclusions:
- Pediatric MS patients exhibit distinct maturational patterns in processing speed.
- Early disease onset and higher intellectual quotient may confer a protective effect on cognitive development in pediatric MS.
Abstract:
Processing speed is a frequently affected cognitive domain in pediatric multiple sclerosis (MS) and is commonly assessed using the Symbol Digit Modalities Test (SDMT). The objective of this study was to determine maturational trajectories in SDMT performance and baseline factors affecting trajectories in a sample of 82 pediatric MS individuals. Performance on the SDMT increased with age in patients with pediatric MS followed by a subsequent decline. Furthermore, patients who were older at disease onset and had a higher IQ showed greater gains with age, suggesting that these factors may be protective with respect to cognitive maturation in pediatric MS.
Related Concept Videos
Information Processing Approach
Pharmacokinetics in Pediatric Patients: Drug Metabolism

